BENGALURU, India–(BUSINESS WIRE)–Biocon Limited (BSE: 532523; NSE: BIOCON) today announced the appointment of Shreehas Tambe as its Chief Executive Officer & Managing Director, effective April 1, 2026, following approvals from the Nomination &…
Category: Business
GenSight Biologics publie ses résultats financiers consolidés estimés pour l’année 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext : SIGHT, ISIN: FR0013183985, éligible PEA-PME), société biopharmaceutique dédiée au développement et à la commercialisation de thérapies géniques innovantes pour les maladies neurodé…
GenSight Biologics Reports Estimated Full-Year Consolidated Financial Results for 2025
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
Long Bridge Medical Receives Clearance from FDA to Initiate the U.S. Pivotal Clinical Study for LensOne Prosthetic Capsular Bag
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Long Bridge Medical, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared initiation of its Investigational Device Exemption (IDE) study for LensOne™, the company’s prosthetic c…
Lineage Launches New Cell Therapy Program in Corneal Endothelial Disease
CARLSBAD, Calif.–(BUSINESS WIRE)—- $LCTX #LineageCellTherapeutics–Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing novel allogeneic, or “off the shelf”, cell therapies for serious med…
Sydnexis Announces New Data from Phase 3 STAR Trial of SYD-101 Presented at 2026 AAPOS Annual Meeting
DEL MAR, Calif.–(BUSINESS WIRE)–Sydnexis, Inc., a biopharmaceutical company focused on developing a novel low-dose atropine formulation to treat pediatric progressive myopia (PPM), today announced new data from comprehensive subgroup analyses from th…
Bausch + Lomb Announces Positive 24-Month U.S. Data on the ELIOS™ System for Treatment of Glaucoma
VAUGHAN, Ontario–(BUSINESS WIRE)–Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced positive 24-month results from the pivotal U.S. clinical trial of …
Cencora to Expand Retina Consultants of America Through Acquisition of EyeSouth Partners’ Retina Business
CONSHOHOCKEN, Pa.–(BUSINESS WIRE)–Cencora, Inc. (NYSE: COR) today announced the signing of a definitive agreement to acquire EyeSouth Partners’ retina business for $1.1 billion. Upon completion of the transaction, the affiliated retina physicians of …
Vision Loss Takes an Emotional Toll. Hadley Is Addressing It.
WINNETKA, Ill.–(BUSINESS WIRE)– #HadleyHelps–Hadley’s free video series on the emotional impact of vision loss draws its strongest early response, pointing to a gap in vision care.
Credo Launches 800G ZeroFlap Optical Transceivers Engineered for AI Networks
SAN JOSE, Calif.–(BUSINESS WIRE)– #WeConnect–Credo launches 800G ZeroFlap optical transceivers engineered for AI networks.
Aldeyra Therapeutics Receives Complete Response Letter from the U.S. Food and Drug Administration for the Reproxalap New Drug Application for the Treatment of Signs and Symptoms of Dry Eye Disease
LEXINGTON, Mass.–(BUSINESS WIRE)–Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated diseases, today announced receipt of a Complete…
Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
JACKSONVILLE, Fla.–(BUSINESS WIRE)–Johnson & Johnson Announces FDA Approval of TECNIS PureSee Intraocular Lens, a Breakthrough Solution for U.S. Cataract Patients
Heru Showcases PretestPro™ for the Heru VR-Powered Diagnostic Headset at Vision Expo
MIAMI–(BUSINESS WIRE)– #AIPoweredVisionDiagnostics–Heru, the leader in AI-powered vision diagnostics, announced it is showcasing the new PretestPro on its Heru wearable platform at Vision Expo 2026.
GenSight Biologics Provides Updates about GS010/LUMEVOQ® Early Access Programs and the Ongoing REVISE Study
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharma company focused on developing and commercializing innovative gene therapies for retinal neurodegenerative diseases and cent…
GenSight Biologics fait le point sur les programmes d’accès précoce de GS010/LUMEVOQ® et sur l’étude REVISE en cours
PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (« GenSight Biologics » ou la « Société ») (Euronext : SIGHT, ISIN : FR0013183985, éligible PEA-PME), société biopharmaceutique en phase clinique, spécialisée dans le développement et la comme…
Lucidis® établit des normes élevées en matière de chirurgie de la cataracte haut de gamme grâce à des performances visuelles complètes
NEUCHÂTEL, Suisse–(BUSINESS WIRE)–Swiss Advanced Vision annonce de nouvelles preuves cliniques confirmant les performances exceptionnelles de sa lentille intraoculaire Lucidis®, renforçant ainsi sa position de solution novatrice en chirurgie de la ca…
STAAR Surgical Issues Shareholder Letter
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today issued a Shareholder Letter on Tuesday, March 3 af…
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2025 Results
LAKE FOREST, Calif.–(BUSINESS WIRE)–STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today reported results for the fourth quarter and fiscal…
ZEISS Vision Care and Medical Eyeglass Center Form Strategic Partnership, Combining Optical Excellence with Patient-Centric Operational Systems
HEBRON, Ky.–(BUSINESS WIRE)–ZEISS Vision Care, one of the world’s leading manufacturers of eyeglass lenses and ophthalmic instruments, today announced a strategic partnership with Medical Eyeglass Center (MEC), a nationally recognized, full-service o…
Samenvatting: Lucidis® stelt hoge normen voor hoogwaardige cataractchirurgie met volledig gezichtsvermogen
NEUCHÂTEL, Zwitserland–(BUSINESS WIRE)–Swiss Advanced Vision maakt nieuwe klinische resultaten bekend die de uitzonderlijke prestaties van zijn Lucidis® intraoculaire lens (IOL) bevestigen, waardoor zijn positie als baanbrekende oplossing in hoogwaar…